- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Tumour Response, in Korea, Republic of
Total 1291 results
-
Asan Medical CenterUnknownFeasibility | Adverse Events | Treatment ResponseKorea, Republic of
-
Samsung Medical CenterCompletedNeuroendocrine TumorKorea, Republic of
-
Seoul National University HospitalCompletedHemodynamic Responses During Tracheal IntubationKorea, Republic of
-
Yonsei UniversityUnknownTumor | Foreign Bodies | Stenosis Trachea | Bronchus TumourKorea, Republic of
-
Jong Hoon LeeUnknownRecurrence | Toxicity | Response to ToxinKorea, Republic of
-
Kangdong Sacred Heart HospitalChungnam National University Hospital; Chungnam National UniversityRecruitingSepsisKorea, Republic of
-
CrystalGenomics, Inc.UnknownSolid TumourKorea, Republic of
-
Gil Joon SuhBiosyn; Boryung Pharmaceutical Co., LtdWithdrawnSepsis | Shock, SepticKorea, Republic of
-
Seoul National University HospitalCompletedHCC | Liver TumorKorea, Republic of
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Seoul National University... and other collaboratorsRecruiting
-
Seoul National University HospitalUnknownin Vitro Fertilization | Poor ResponderKorea, Republic of
-
Seoul National University HospitalCompletedPheochromocytoma | Extra-adrenal Paraganglioma | Non-functioning CarcinoidKorea, Republic of
-
Yonsei UniversityCompleted
-
Catholic Kwandong UniversityKorea University Guro HospitalCompletedImmune Response | SafetyKorea, Republic of
-
Yonsei UniversityMerck KGaA, Darmstadt, GermanyActive, not recruitingPD-L1 Positive Mutation Tumor | EBV Positive Mutation Tumor | MSI-H Mutation Tumor | POLE/POLD1 Mutation TumorKorea, Republic of
-
Seoul National University HospitalCompletedColorectal TumorKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Jongmin LeeCompletedSepsis | Immune DeficiencyKorea, Republic of
-
Samsung Medical CenterUnknownLiver Failure | SepsisKorea, Republic of
-
Samsung Medical CenterTerminated
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterWithdrawnRefractory Solid TumorsKorea, Republic of
-
Asan Medical CenterCompleted
-
Samsung Medical CenterMinistry of Health, Republic of KoreaNot yet recruitingRelapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Yonsei UniversityCompletedSevere Sepsis or Septic ShockKorea, Republic of
-
Seoul National University HospitalRecruiting
-
Seoul National University HospitalSeoul National University Bundang HospitalRecruitingHospital Rapid Response Team | Hospital Medical Emergency Team | Medicine, EmergencyKorea, Republic of
-
Seoul National University HospitalCompleted
-
Seoul National University HospitalCompletedHematologic Diseases | Bacteremia SepsisKorea, Republic of
-
Samsung Medical CenterCompletedSolid TumorKorea, Republic of
-
Samsung Medical CenterWithdrawnSolid TumorKorea, Republic of
-
Asan Medical CenterCompleted
-
Samsung Medical CenterCompleted
-
Samsung Medical CenterCompleted
-
Samsung Medical CenterWithdrawn
-
Yonsei UniversityCompleted
-
Kyunghee University Medical CenterCompletedSolid Tumor, AdultKorea, Republic of
-
Korea Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.CompletedSolid TumorKorea, Republic of
-
Seoul National University HospitalUnknown
-
Seoul National University HospitalRecruitingPituitary Adenoma | Meningioma | Schwannoma | Brain Tumor, Primary | Gliomas BenignKorea, Republic of
-
EutilexRecruiting
-
Yung-Jue BangTerminated
-
Yonsei UniversityUnknownMalignant TumorKorea, Republic of
-
The Korean Society of Pediatric Hematology OncologyUnknownPediatric Solid TumorKorea, Republic of
-
SPARK BiopharmaRecruiting
-
Hanmi Pharmaceutical Company LimitedSeoul National UniversityCompletedAdvanced Solid TumorKorea, Republic of
-
Korea Otsuka Pharmaceutical Co., Ltd.UnknownSolid TumorKorea, Republic of
-
Samsung Medical CenterCompletedMycoses | Brain Tumor | Neuroblastoma | Retinoblastoma | Wilms TumorKorea, Republic of
-
Seoul National University HospitalRecruitingHepatocellular Carcinoma | Atezolizumab-bevacizumab | Response EvaluationKorea, Republic of